As of 2025-11-19, the Intrinsic Value of Pharmasimple SA (ALPHS.PA) is 2.75 EUR. This ALPHS.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.01 EUR, the upside of Pharmasimple SA is 21,233.90%.
The range of the Intrinsic Value is 1.99 - 4.27 EUR
Based on its market price of 0.01 EUR and our intrinsic valuation, Pharmasimple SA (ALPHS.PA) is undervalued by 21,233.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 1.99 - 4.27 | 2.75 | 21233.9% |
| DCF (Growth 10y) | 9.58 - 18.09 | 12.42 | 96207.2% |
| Fair Value | -0.79 - -0.79 | -0.79 | -6,205.15% |
| EPV | 7.99 - 8.04 | 8.01 | 62018.1% |
| DDM - Stable | (1.25) - (2.85) | (2.05) | -15964.0% |
| DDM - Multi | 1.42 - 2.54 | 1.82 | 14023.4% |
| Market Cap (mil) | 0.12 |
| Beta | 0.79 |
| Outstanding shares (mil) | 9.65 |
| Enterprise Value (mil) | 4.31 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.91% |
| Cost of Debt | 5.00% |
| WACC | 5.06% |